Hiroaki Kato

2.6k total citations · 1 hit paper
109 papers, 1.9k citations indexed

About

Hiroaki Kato is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Hiroaki Kato has authored 109 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 44 papers in Surgery and 34 papers in Oncology. Recurrent topics in Hiroaki Kato's work include Gastric Cancer Management and Outcomes (26 papers), Esophageal Cancer Research and Treatment (16 papers) and Ocular Surface and Contact Lens (12 papers). Hiroaki Kato is often cited by papers focused on Gastric Cancer Management and Outcomes (26 papers), Esophageal Cancer Research and Treatment (16 papers) and Ocular Surface and Contact Lens (12 papers). Hiroaki Kato collaborates with scholars based in Japan, United States and Australia. Hiroaki Kato's co-authors include Norihiko Yokoi, Shigeru Kinoshita, Kazuo Tsubota, Yukiko Sonomura, Aoi Komuro, Junichi Goto, Toshio Nambara, Motoko Kawashima, Murat Doğru and Yuichi Uchino and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hiroaki Kato

101 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Dry Eye Disease and its Risk Factors in Visual Display Terminal Users: The Osaka Study

2013 313 citations Norihiko Yokoi, Aoi Komuro et al. profile →

Peers

Countries citing papers authored by Hiroaki Kato

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kato more than expected).

Fields of papers citing papers by Hiroaki Kato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kato. The network helps show where Hiroaki Kato may publish in the future.

Co-authorship network of co-authors of Hiroaki Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kato. A scholar is included among the top collaborators of Hiroaki Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kato. Hiroaki Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Initial reduction of the primary tumor or lymph nodes: which is the better prognostic factor in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemotherapy followed by surgery? 2025 ·Esophagus ·(unknown), Osamu Shiraishi, (unknown), Atsushi Yamada, (unknown), (unknown), (unknown), Hiroaki Kato, Atsushi Yasuda, Masayuki Shinkai, Motohiro Imano, Takushi Yasuda	1
2	Risk factors and prognosis for supraclavicular lymph node metastasis in patients with thoracic esophageal cancer. Distant or regional metastasis? 2024 ·Diseases of the Esophagus ·Osamu Shiraishi, (unknown), (unknown), Hiroaki Kato, (unknown), (unknown), Atsushi Yasuda, Masayuki Shinkai, Motohiro Imano, Takushi Yasuda	2
3	A randomized study comparing electronic patient-reported outcome (ePRO) monitoring with routine follow-up during trastuzumab deruxtecan treatment in patients with metastatic breast cancer (PRO-DUCE study). 2024 ·Journal of Clinical Oncology ·Yuichiro Kikawa, Yukari Uemura, Tetsuhiko Taira, Chiyoe Kitagawa, Hideki Maeda, Hiroaki Kato, Naoki Hashimoto, Mitsuchika Hosoda, Yohei Hamanaka, Yuko Tanabe, Tsutomu Yoshida, (unknown), Daisuke Takabatake, Takashi Ishikawa, Takayuki Iwamoto, Takeshi Yamaguchi, (unknown), Hirofumi Mukai, Naruto Taira, Takafumi Sangai	1
4	Impact of Relative Dose Intensity of Docetaxel, Cisplatin, and 5-Fluorouracil Neoadjuvant Chemotherapy on Survival of Esophageal Squamous Cell Cancer Patients 2023 ·Oncology ·Osamu Shiraishi, Hiroaki Kato, Kota Momose, (unknown), Atsushi Yasuda, Masayuki Shinkai, Motohiro Imano, Takushi Yasuda	6
5	Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer Patients. 2022 ·PubMed ·(unknown), Naruto Taira, Kosuke Kashiwabara, Junji Tsurutani, Masahiro Kitada, Masato Takahashi, Hiroaki Kato, Yuichiro Kikawa, (unknown), Yoichi Naito, Yoshie Hasegawa, Tsuyoshi Saito, Tsutomu Iwasa, Tsutomu Takashima, Tomohiko Aihara, Hirofumi Mukai, Fumikata Hara, Tadahiko Shien, Hiroyoshi Doihara, Shinichi Toyooka	1
6	The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma 2022 ·BMC Cancer ·Hayato Kaida, Takushi Yasuda, Osamu Shiraishi, Hiroaki Kato, Yutaka Kimura, Kohei Hanaoka, Minoru Yamada, (unknown), Masakatsu Tsurusaki, Kazuhiro Kitajima, Satoshi Hattori, Kazunari Ishii	2
7	Immuno-genomic profiling of biopsy specimens predicts neoadjuvant chemotherapy response in esophageal squamous cell carcinoma 2022 ·Cell Reports Medicine ·Shota Sasagawa, Hiroaki Kato, Koji Nagaoka, Changbo Sun, Motohiro Imano, Takao Satô, Todd A. Johnson, Masashi Fujita, Kazuhiro Maejima, (unknown), Kazuhiro Kakimi, Takushi Yasuda, Hidewaki Nakagawa	10
8	Comparison of Aggressive Planned Salvage Surgery Versus Neoadjuvant Chemoradiotherapy Plus Surgery for Borderline Resectable T4 Squamous Cell Carcinoma 2021 ·Annals of Surgical Oncology ·Osamu Shiraishi, Takushi Yasuda, Hiroaki Kato, Kota Momose, (unknown), Atsushi Yasuda, Masayuki Shinkai, Yutaka Kimura, Motohiro Imano	5
9	A comparative study of the lengths of different reconstruction routes used after thoracic esophagectomy 2021 ·Esophagus ·Takushi Yasuda, Osamu Shiraishi, Hiroaki Kato, (unknown), Kota Momose, Atsushi Yasuda, Masayuki Shinkai, Yutaka Kimura, Motohiro Imano	6
10	Relevance of Aortic Dissection Chronicity to the Development of Stent Graft–induced New Entry 2020 ·The Annals of Thoracic Surgery ·(unknown), Noriyuki Kato, Hiroaki Kato, (unknown), Hisato Ito, Ken Nakajima, Shuji Chino, Toshiya Tokui, (unknown), Hajime Sakuma	10
11	Relationship between the meniscus parameters evaluated by different methods 2019 ·Investigative Ophthalmology & Visual Science ·Yukiko Sonomura, Norihiko Yokoi, Rieko Sakai, Hiroaki Kato, Aoi Komuro, Chie Sotozono	1
12	Intraperitoneal and Systemic Chemotherapy for Patients with Gastric Cancer with Peritoneal Metastasis: A Phase II Trial 2018 ·Anticancer Research ·Masayuki Shinkai, Motohiro Imano, Yasutaka Chiba, (unknown), Hiroaki Kato, (unknown), Osamu Shiraishi, Atsushi Yasuda, Masahiro Tsubaki, Shozo Nishida, Yutaka Kimura, Takushi Yasuda	16
13	De Novo Malignancy Following Adult-to-Adult Living Donor Liver Transplantation Focusing on Posttransplantation Lymphoproliferative Disorder 2018 ·Transplantation Proceedings ·Shugo Mizuno, Aoi Hayasaki, Takeshi Ito, Takehiro Fujii, Yusuke Iizawa, Hiroaki Kato, Yasuhiro Murata, Akihiro Tanemura, Naohisa Kuriyama, Y. Azumi, Masashi Kishiwada, Masanobu Usui, Hiroyuki Sakurai, Shuji Isaji	5
14	Relationship between lid-wiper epitheliopathy, tear abnormalities, and blink in dry-eye patients 2015 ·Investigative Ophthalmology & Visual Science ·Hiroaki Kato, Norihiko Yokoi, (unknown), Rieko Sakai, Akihide Watanabe, Shigeru Kinoshita	1
15	Evaluation of reading speed ability in glaucoma patients with central visual field defects 2014 ·Investigative Ophthalmology & Visual Science ·Kojiro Imai, Junko Takahashi, Kazuhiko Mori, Hiroaki Kato, Yoko Ikeda, Morio Ueno, (unknown), Shigeru Kinoshita	1
16	The correlations between tear deficiency and conjunctival epithelial damage in dry eye 2014 ·Investigative Ophthalmology & Visual Science ·Yukiko Sonomura, Norihiko Yokoi, Hiroaki Kato, (unknown), Aoi Komuro, Shigeru Kinoshita	3
17	Anti-Tumor Necrosis Factor Therapy Inhibits Lung Metastasis in an Osteosarcoma Cell Line 2014 ·Oncology ·Hiroaki Kato, Hiroki Wakabayashi, Yohei Naito, (unknown), T Nakagawa, Akihiko Matsumine, Akihiro Sudo	19
18	Early removal of drains and the incidence of seroma after breast surgery 2013 ·Breast Cancer ·Naoya Okada, (unknown), Minoru Takada, Hiroaki Kato, Yoshiyasu Ambo, Fumitaka Nakamura, Akihiro Kishida, Nobuichi Kashimura	25
19	A CASE OF RETROPERITONEAL LIPOSARCOMA PRESENTED AS A BULGING MASS IN THE RIGHT INGUINAL AREA 2010 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Satoshi Kubota, Yoshinori Kagawa, Hiroaki Kato, Junzo Shimizu, Kimimasa Ikeda, (unknown)	1
20	High‐dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer 2002 ·International Journal of Urology ·Kiyoshi Koshida, Hiroaki Kato, Atsushi Mizokami, Hiroshi Morishita, (unknown), Kazuto Komatsu, (unknown), Tadao Uchibayashi, Shintaro Shiobara, Mikio Namiki	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact